Clinical Trial Update: Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing rapamycin to mycophenolate mofetil in kidney-pancreas transplant recipients for Type 1 diabetes mellitus has completed. Results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Rapamune (sirolimus)

Snippet

Sponsor: University of Miami | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2017-07-12